Tuesday, August 9, 2011

Pharmacology names

      
From CC.


                                                                   
In pharmacology, all drugs have two names, a trade name and generic name. 
Example, the trade name is Tylenol and it's generic name is Acetaminophen.
Aleve is also called Naproxen.. Amoxil is also called Amoxicillin and     
Advil is also called Ibuprofen.                                           
                                                                           
The FDA has been looking for a generic name for Viagra. After careful     
consideration by a team of government experts, it recently ann ounced that
it has settled on the generic name of Mycoxafloppin. Also considered were 
Mycoxafailin, Mydixadrupin, Mydixarizin, Dixafix, and of course, Ibepokin.
                                                                           
                                                                           
Pfizer Corp. ann ounced today that Viagra will soon be available in liquid
form, and will be marketed by Pepsi Cola as a power beverage suitable for 
use as a mixer. It will now be possible for a man to literally pour       
himself a stiff one. Obviously we can no longer call this a soft drink,   
and it gives new meaning to the names of 'cocktails', 'highballs' and just
a good old-fashioned 'stiff drink'. Pepsi will market the new concoction 
by the name of: MOUNT & DO.                                               
                                                                           
Thought for the day: There is more money being spent on breast implants   
and Viagra today than on Alzheimer's research. This means that by 2040,   
there should be a large elderly population with perky boobs and huge     
erections and absolutely no recollection of what to do with them.         
                                                                           
If you don't send this to five old friends right away, there will be five 
fewer people laughing in the world .                                     
                                                                    

0 comments: